Weight change over two years in people prescribed olanzapine, quetiapine and risperidone in UK primary care: Cohort study in THIN, a UK primary care database

BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment

(2016) Stephen J Cooper et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Depression as a Risk Factor for the Initial Presentation of Twelve Cardiac, Cerebrovascular, and Peripheral Arterial Diseases: Data Linkage Study of 1.9 Million Women and Men

(2016) Marina Daskalopoulou et al.   PLoS One

Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management

(2015) P. Manu et al.   ACTA PSYCHIATRICA SCANDINAVICA

Cardiovascular Risk Prediction Models for People With Severe Mental Illness

(2015) David P. J. Osborn et al.   JAMA Psychiatry

Weight gain and antipsychotics: a drug safety review

(2014) Richard Musil et al.   Expert Opinion On Drug Safety

Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis

(2014) Maarten Bak et al.   PLoS One

Prescribing of antipsychotics in UK primary care: a cohort study

(2014) Louise Marston et al.   BMJ Open

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

(2013) Stefan Leucht et al.   LANCET

Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey

(2013) Carmen Moreno et al.   World Psychiatry

Weight Change From 3-Year Observational Data

(2012) Chris J. Bushe et al.   JOURNAL OF CLINICAL PSYCHIATRY

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

Creating medical and drug code lists to identify cases in primary care databases

(2009) Shreya Davé et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The importance of defining periods of complete mortality reporting for research using automated data from primary care

(2008) Andrew Maguire et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY